AA
TDACW

AQR Arbitrage’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

AQR Arbitrage’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.7K Sell
547,517
-2,475
-0.5% -$567 ﹤0.01% 494
2025
Q4 		$170K Hold
549,992
– – ﹤0.01% 385
2025
Q3 		$159K Sell
549,992
-192,505
-26% -$52.1K ﹤0.01% 358
2025
Q2 		$186K Hold
742,497
– – ﹤0.01% 310
2025
Q1 		$116K Buy
+742,497
New +$131K ﹤0.01% 322

Other funds holding TDACW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

AQR Arbitrage's TDACW Position: Q1 2026 in Review

AQR Arbitrage reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 0.45% in Q1 2026, selling an estimated $567 and leaving 547,517 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

AQR Arbitrage first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $186K in Q2 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • AQR Arbitrage held 547,517 shares of Translational Development Acquisition Corp Warrants worth $65.7K as of Q1 2026.
  • AQR Arbitrage sold 2,475 Translational Development Acquisition Corp Warrants shares in Q1 2026, an estimated $567.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of AQR Arbitrage's portfolio in Q1 2026, its #494 holding.
  • AQR Arbitrage first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
  • AQR Arbitrage's Translational Development Acquisition Corp Warrants position peaked at $186K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.